APA (7th ed.) Citation

Hurley, K., Rubin, L. R., Werner‐Lin, A., Sagi, M., Kemel, Y., Stern, R., . . . Offit, K. (2012). Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations. Cancer, 118(24), 6270-6277. https://doi.org/10.1002/cncr.27695

Chicago Style (17th ed.) Citation

Hurley, Karen, et al. "Incorporating Information Regarding Preimplantation Genetic Diagnosis into Discussions Concerning Testing and Risk Management for BRCA1/2 Mutations." Cancer 118, no. 24 (2012): 6270-6277. https://doi.org/10.1002/cncr.27695.

MLA (9th ed.) Citation

Hurley, Karen, et al. "Incorporating Information Regarding Preimplantation Genetic Diagnosis into Discussions Concerning Testing and Risk Management for BRCA1/2 Mutations." Cancer, vol. 118, no. 24, 2012, pp. 6270-6277, https://doi.org/10.1002/cncr.27695.